Skip to main content
logo
Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
11.59
+1.44 (14.19%)
At close: Jul 29, 2026, 4:00 PM EDT
12.00
+0.41 (3.54%)
Pre-market: Jul 30, 2026, 8:18 AM EDT

Anbio Biotechnology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7.7711.769.697.14.18
Short-Term Investments
4.13--1.57-
Cash & Short-Term Investments
11.911.769.698.674.18
Cash Growth
1.19%21.40%11.75%107.33%-
Accounts Receivable
3.661.061.88-0.72
Inventory
---0.35-
Other Current Assets
14.695.714.184.920.02
Total Current Assets
30.2418.5315.7513.944.92
Net Property, Plant & Equipment
--0.01--
Other Long-Term Assets
-0.390.060-
Total Assets
30.2418.9215.8113.964.92

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
-1.630.831.411.89
Unearned Revenue
----0.49
Other Current Liabilities
0.090.10.170-
Total Current Liabilities
0.091.730.991.412.38
Total Liabilities
0.091.730.991.412.38

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.01--
Additional Paid-in Capital
6.5600--
Retained Earnings
23.5817.1714.812.552.54
Shareholders' Equity
30.1617.1914.8212.552.54
Total Liabilities & Equity
30.2418.9215.8113.964.92

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
11.911.769.698.674.18
Net Cash Growth
1.19%21.40%11.75%107.33%-
Net Cash Per Share
0.270.280.4586690.5641813.25
Book Value
30.1617.1914.8212.552.54
Book Value Per Share
0.690.410.69125470.0025358.10
Tangible Book Value
30.1617.1914.8212.552.54
Tangible Book Value Per Share
0.690.410.69125470.0025358.10
SEC Filings: 10-K · 10-Q